Zentalis Pharmaceuticals financial statements
젠테일스 파머슈티컬NASDAQ:ZNTL · Nasdaq · Healthcare · sector #17$2.67-3.96%
2026-10-06 closeZentalis Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $67M. 2024 operating profit was −$191M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy